Delivery Order SPE2DB20D3101-SPE2DB25FRSE4
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on July 15, 2025, for M-M-R II vaccine vials valued at $23,094.80. This firm fixed price delivery order, which carries an ultimate completion date of July 16, 2025, is unset-aside and represents a competitive award under AmerisourceBergen's existing federal contract vehicle. The place of performance is located in Conshohocken,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 5, 2025, for MMR II vaccine vials valued at $3,776.61. This competitively awarded, firm fixed-price delivery order is scheduled for ultimate completion by August 6, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, PA. The award carries no set-aside designation,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order for M-M-R II vaccine vials valued at $3,269.25 on August 25, 2025, with an ultimate completion date of August 26, 2025. This firm fixed-price delivery order was issued under a competitively awarded, non-set-aside procurement by the Medical Supply Chain, a defense-focused federal agency supporting military and veteran healthcare systems. The contract represents...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $1,119.10 by the Defense Logistics Agency (DLA) for M-M-R II vaccine vials. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 5, 2025, and represents a continuation of the company's extensive pharmaceutical supply relationship with DLA. The award carries no set-aside designation and will be performed at the vendor's corporate office...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency valued at $2,882.55 for M-M-R II vaccine vials. The contract was awarded on September 17, 2025, with an ultimate completion date of September 18, 2025, under a firm fixed-price arrangement with no set-aside designation. The delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency (DLA) for M-M-R II vaccine vials valued at $2,939.10. This competitively awarded, firm fixed-price contract is scheduled for completion by July 23, 2025, with performance to be conducted at the vendor's corporate office location in Conshohocken, PA. The award represents a child order under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency for M-M-R II vaccine vials valued at $4,069.61 with a firm fixed price structure. The award was made on September 9, 2025, with an ultimate completion date of September 10, 2025, and was not designated as a set-aside contract. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $15,679.50 by the Defense Logistics Agency (DLA) for M-M-R II vaccine vials, with an ultimate completion date of August 12, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award status. Performance will be executed at the contractor's Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of M-M-R II vaccine vials, with a ceiling value of $4,185.90. This competitively awarded, firm fixed-price contract is classified as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The performance location is AmerisourceBergen's corporate headquarters...
- The Defense Logistics Agency awarded a delivery order valued at $1,462.82 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on July 18, 2025, with an ultimate completion date of July 21, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRSE4Delivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 11, 2025, for M-M-R II vaccine vials with a ceiling value of $2,330.79. This firm fixed-price delivery order, which is not associated with any set-aside designation, is expected to be completed by August 12, 2025, and will be performed at the contractor's Conshohocken facility. The award represents a routine pharmaceutical supply transaction within the federal medical procurement system. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999.99 million and extends through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including vaccines, specialty medications, and related medical commodities for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 8/11/25 |